FDA Inspection 976726 — Oklahoma Blood Institute Northwest

Oklahoma Blood Institute Northwest — FEI 1626218

The FDA completed an inspection of Oklahoma Blood Institute Northwest on May 12, 2016 in Enid, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 12, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Enid, OK (United States)